Medical Oncologist

Dr. Katherine Robinson

DVM, DACVIM (Oncology)

My Commitment To You

To our referring partner veterinarians, my commitment is: to be available to collaborate on cases and partner in education of the client and referring veterinarians to promote well-being of our oncology patients.
To pet owners, my commitment is: to give you honest, clear, evidence-based advice and recommendations to help you make informed decisions regarding oncologic care for your beloved companion with the focus on preserving quality of life.
– Dr. Katie Robinson


Dr. Katherine Robinson is a proud native of Ohio who is excited to now call the beautiful Pacific coast home. After pursuing her education across the United States, from veterinary school and residency training at the University of Missouri to internships in Wisconsin and Georgia, Dr. Robinson settled in Seattle where she served as the medical oncologist for a large referral hospital. While she thrived in the fast-paced environment of a busy corporate hospital, Dr. Robinson had a strong desire to serve patients in a different setting. She is thrilled to have joined BBVSH and have the opportunity to practice in an independently owned clinic that allows her to live her values and put patient care first.

Dr. Robinson’s special interests include comparative and translational oncology, the diversity of lymphoproliferative disorders, and histiocytic disease. Dr. Robinson’s philosophy regarding oncologic care is that cancer treatment should only be pursued if there is likelihood that it will improve the patient’s quality of life. She is firm believer in “Just because you can doesn’t mean you should.” Dr. Robinson believes that owners make the best decisions when they are properly informed of treatment options and expected outcomes, and it is her duty to provide that for the owners of her patients. Dr. Robinson understands that hearing a diagnosis of cancer in your companion can be scary, and she is committed to making her clients feel comfortable by providing compassionate care and kindness.

When she is not at work, Dr. Robinson enjoys the outdoors by paddle boarding, hiking, savoring a good meal or having a beer on a patio, or just watching the sunset over the mountains from her balcony. She also enjoys playing basketball, attending concerts, watching sporting events (Go Buckeyes!), and traveling. She lives with her partner and their two cats: a sassy tuxedo named Bootsy and a sophisticated Norwegian Forest Cat mix named Sampson.


  • University of Missouri - Medical Oncology Residency
  • University of Wisconsin - Oncology Clinical Trials Internship
  • University of Georgia - Small Animal Rotating Medicine & Surgery Internship
  • University of Missouri - Doctor of Veterinary Medicine (Phi Zeta Honor Society Member)
  • The Ohio State University - Bachelor of Science, Zoology
  • Kim Ringen Translational Oncology Award from University of Missouri CVM (2016)
  • Diplomate of the American College of Veterinary Internal Medicine (Oncology)
  • Robinson KL, Bryan ME, Atkinson ES, Keeler MR, Hahn AW, Bryan JN. Neutering is associated with developing hemangiosarcoma in dogs in the Veterinary Medical Database: An age and time-period matched case-control study (1964-2003). Can Vet J. 2020;61(5):499-504.
  • Kumar SR, Bryan JN, Eaton AM, Robinson KL, Gajagowni S. Differential Modulation of Transcription Factors and Cytoskeletal Proteins in Prostate Carcinoma Cells by a Bacterial Lactone. Biomed Res Int. 2018;2018:6430504. Published 2018 May 9. doi:10.1155/2018/6430504
  • Kumar SR , Kim DY , Henry CJ , Bryan JN , Robinson KL , and Eaton AM . Programmed death ligand 1 is expressed in canine B cell lymphoma and downregulated by MEK inhibitors, Vet Comp Oncol, 2017 Dec;15(4):1527-1536.
  • Maitz CA, Robinson KL. Use of an electronic brachytherapy surface applicator to treat an epiglottal fibrosarcoma in a dog. Vet Radiol Ultrasound. 2017 Jul;58(4):E45-E48.
  • Pellin MA, Wouda RM, Robinson K, Tsimbas K, Kurzman ID, Biller BJ, Vail DM. Safety evaluation of combination doxorubicin and toceranib phosphate (Palladia®) in tumour bearing dogs: a phase I dose-finding study. Vet Comp Oncol. 2017 Sep;15(3);919-931.
  • Chang CH, Lee-Fowler TM, DeClue AE, Cohn LA, Robinson KL, Reinero CR. The impact of oral versus inhaled glucocorticoids on allergen specific IgE testing in experimentally asthmatic cats. Vet Immunol Immunopathol. 2011 Dec 15; 144(3-4): 437-41.

To Referring Vets

Request an Oncology consult

Come visit us or ask us to visit you!


Pet Owners:


Contact us to inquire about our experience with a particular procedure or any other question that will help you make an informed decision.

Request a Vet to Vet Consult

Our specialists see themselves as extensions of your team and that means you can count on them like teammates. If you would like to speak to a specialist about a challenging case please phone our reception and ask for a doctor by name or by department.

(604) 514-8383

Come Visit Us

Boundary Bay is an extension of your team and teammates should get to know one another. We invite you to arrange a time to tour our facility and get to know some of the specialists. Fill in the form below to get the process started.

    We’ll Visit You

    We’re committed to helping your clinic succeed. If possible, we’ll come visit you in person to establish a relationship and/or to arrange CE sessions for your staff (lunch ‘n learns, etc). Fill in the form below to start a conversation about what your clinic needs.

      Ask Us a Question

      We’ll do everything in our power to help you make an informed decision!